Sample pre-treatment determines the clinical usefulness of acid-labile subunit immunoassays in the diagnosis of growth hormone deficiency and acromegaly

European Journal of Endocrinology

Volumn 156, Issue 3, 2007, Pages 331-339

  Morrison, Katherine M ^c   Bidlingmaier, Martin ^a   Stadler, Simone ^a   Wu, Zida ^a,d   Skriver, Lars ^b   Strasburger, Christian J ^a,d  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b L and K Biosciences ApS   (Denmark)

^c MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCINE; GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; UREA;

ACROMEGALY; ADULT; ARTICLE; BLOOD SAMPLING; BRAIN SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; MALE; MEDICAL RECORD; MICROADENOMA; MOLECULAR WEIGHT; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ACROMEGALY; ADULT; CARRIER PROTEINS; CHROMATOGRAPHY, GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FREEZING; GLYCOPROTEINS; HUMAN GROWTH HORMONE; HUMANS; IMMUNOASSAY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MALE; MIDDLE AGED; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 34147118663     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-06-0592     Document Type: Article

References (22)

1. Baxter RC. Circulating levels and molecular distribution of the acid-labile subunit of the high molecular weight insulin-like growth factor-binding protein complex. Journal of Clinical Endocrinology and Metabolism 1990 70 1347-1353.
2. Chin E, Zhou J, Dai J, Baxter RC & Bondy CA. Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex. Endocrinology 1994 134 2498-2504.
3. Labarta J, Gargosky SE, Simpson DM, Lee PDK, Argente J, Guevara-Aguirre J & Rosenfeld RG. Immunoblot studies of the acid-labile subunit (ALS) in biological fluids, normal human serum and in children with GH deficiency and GH receptor deficiency before and after long-term therapy with GH or IGF-I respectively. Clinical Endocrinology 1997 47 657-666.
4. Khosravi MJ, Diabandi A, Mistry J, Krishna RG & Khare A. Acid-labile subunit of human insulin-like growth factor-binding protein complex: measurement, molecular, and clinical evaluation. Journal of Clinical Endocrinology and Metabolism 1997 82 3944-3951.
5. Barrios V, Argente J, Munoz MT, Pozo J, Chowen JA & Hernandez M. Diagnostic interest of acid-labile subunit measurement in relationship to other components of the IGF system in pediatric patients with growth or eating disorders. European Journal of Endocrinology 2001 144 245-250.
6. Trivin C, Souberbielle JC, Aubertin G, Lawson-Body E, Adan L & Brauner R. Diagnosis of idiopathic growth hormone deficiency: contributions of data on the acid-labile subunit, insulin-like growth factor (IGF)-I and-II, and lGF binding protein-3. Journal of Pediatric Endocrinology and Metabolism 2006 19 481-489.
7. DeBoer H, Blok GJ, Popp-Snijders C, Stuurman C, Baxter RC & van der Veen E. Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers. Journal of Clinical Endocrinology and Metabolism 1996 81 1371-1377.
8. Stadler S, Wu Z, Dressendorfer RA, Morrison KM, Khare A, Lee PD & Strasburger CJ. Monoclonal anti-acid-labile subunit oligopeptide antibodies and their use in a two-site immunoassay for ALS measurement in humans. Journal of Immunological Methods 2001 252 73-82.
9. Mandel SH, Moreland E, Rosenfeld RG & Gargosky SE. The effect of GH therapy on the immunoreactive forms and distribution of IGFBP-3, IGF-I, the acid-labile subunit, and growth rate in GH-deficient children. Endocrine 1997 7 351-360.
10. Baxter RC, Svejkar M, Khosravi MJ, Bennett GL, Hardman KV, Senese A, Mistry J, Walton PE & Quarmby V Measurement of the acid-labile subunit of the insulin-like growth factor binding protein complex in human serum: a comparison of four immunoassays. Journal of Endocrinology 2000 165 271-279.
11. Tzanela M, Christoforaki M, Papastathopoulou L, Vassiliadi D, Botoula E, Trivizas P & Thalassinos NC. Growth hormone binding protein and acid labile subunit levels in the assessment of acromegaly treatment. Hormones (Athens) 2005 4 148-154.
12. Arosio M, Garrone S, Bruzzi P, Faglia G, Minuto F & Barreca A. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3. Journal of Clinical Endocrinology and Metabolism 2001 86 1091-1098.
13. Marzullo P, Di Somma C, Pratt KL, Khosravi J, Diamandis A, Lombardi G, Colao A & Rosenfeld RG. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults. Journal of Clinical Endocrinology and Metabolism 2001 86 3001-3008.
14. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. Journal of Clinical Endocrinology and Metabolism 1998 83 379-381.
15. Simel DL, Samsa GP & Matchar DB. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. Journal of Clinical Epidemiology 1991 44 763-770.
16. Blum WF & Breier BH. Radioimmunoassays for IGFs and IGFBPs. Growth Regulation 1994 4 (Suppl 1) 11-19.
17. Wu Z, Bidlingmaier M, Liu C, De Souza EB, Tschop M, Morrison KM & Strasburger CJ. Quantification of the soluble leptin receptor in human blood by ligand-mediated immunofunctional assay. Journal of Clinical Endocrinology and Metabolism 2002 87 2931-2939.
18. Juul A, Moller S, Mosfeldt-Laursen E, Rasmussen MH, Scheike T, Pedersen SA, Kastrup KW, Yu H, Mistry J, Rasmussen S, Müller J, Henriksen J & Skakkebaek NE. The acid-labile subunit of human ternary insulin-like growth factor binding protein complex in serum: hepatosplanchnic release, diurnal variation, circulating concentrations in healthy subjects, and diagnostic use in patients with growth hormone deficiency. Molecular Endocrinology 1998 83 4408-4415.
19. Sneppen SB, Lange M, Pedersen LM, Kristensen L, Main KM, Juul A, Skakkebwk NE & Feldt-Rasmussen U. Total and free insluin-like growth factor I, insulin-like growth factor binding protein 3 and acid-labile subunit reflect clinical activity in acromegaly. Growth Hormone and IGF Research 2001 11 384-391.
20. Grinspoon S, Clemmons D, Swearingen B & Klibanski A. Serum insluin-like growth factor-binding protein 3 levels in the diagnosis of acromegaly. Journal of Clinical Endocrinology and Metabolism 1995 80 927-932.
21. Dill KA. Denatured states of proteins. Annual Review of Biochemistry 1991 60 795-825.
22. Das TK, Mazumdar S & Mitra S. Characterization of a partially unfolded structure of cytochrome c induced by sodium dodecyl sulphate and the kinetics of refolding. European Journal of Biochemistry 1998 254 662-670.